Victoria E. VanStekelenburg

Washington, D.C.
  • 555 Eleventh Street, NW
  • Suite 1000
  • Washington, D.C. 20004-1304
  • USA

Victoria VanStekelenburg is an associate in the Washington, D.C. office of Latham & Watkins.

Ms. VanStekelenburg’s practice focuses on mergers and acquisitions and other complex business transactions, including leveraged buyouts, joint ventures, divestitures, controlling and minority investments, and other strategic transactions, as well as general corporate governance and transactional matters. She has extensive experience representing private equity firms as well as private and public companies in domestic and cross-border transactions across a variety of industries, including manufacturing, healthcare, consumer products, and energy.

Ms. VanStekelenburg previously served as Co-Chair of firm’s D.C. Women Lawyers Group, Associates Committee, and on the firm’s Training & Career Enhancement Committee, which develops and oversees in-house training and mentoring programs for associates.

Ms. VanStekelenburg’s experience includes representing:

  • Platinum Equity in its joint venture with Ball Corp and acquisition of Ball Corp’s tinplate food and aerosol packaging businesses
  • The Carlyle Group in connection with its €10.1 billion leveraged acquisition of AkzoNobel’s specialty chemicals business
  • Platinum Equity in its US$3.85 billion acquisition of Husky Injection Molding Systems, a leading supplier of injection molding equipment and services to the global plastics industry
  • Capitol Acquisition Corporation III in its combination with Cision at an enterprise value of approximately US$2.4 billion
  • The Carlyle Group in its take-private acquisition with GTCR of Albany Molecular Research, Inc.
  • Carlyle in the sale of Landmark Aviation, an operator of a global network of fixed-base operations (FBOs), aircraft maintenance and aircraft management, and charter businesses, to BBA Aviation plc for US$2.07 billion
  • Pharmaceutical Product Development, a leading global contract research organization, in its acquisition from Symphony Technology Group of Evidera
  • Platinum Equity in its divestiture of the European and Asian operations of Mactac, a global pressure-sensitive materials business, to Avery Dennison for €200 million
  • An investment fund and asset management business, specializing in the acquisition of cash flows arising from intellectual property in film, television, and music, in the sale of its asset management business to a blue-chip private equity firm
  • Carlyle in the sale of Primatics Financial, an enterprise software company, to SS&C Technologies Holdings for approximately US$122 million
  • Carlyle in its acquisition of Ortho-Clinical Diagnostics, a global provider of solutions for screening and confirming diseases, from Johnson & Johnson for US$4.15 billion

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.